Clinical Trial Update: A Study of Duloxetine in the Treatment of Fibromyalgia [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating duloxetine for fibromyalgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED